Rabia is Senior Technical Advisor for Pharmaceutical Policy and Governance of SAFEMed, Ukraine. While working full time, Dr. Rabia continues to remain as Chair of the HTAi Medical Devices Interest Group of HTAi and the Chair of Eurasian HTA Initiative with institutional members from 9 countries. She is one of the past Directors of International Health Technology Assessment Society (HTAi), and the past-Chair and current steering committee member of HTAi Developing Countries Interest Group with members in over 50 countries.
Prior to her position in SAFEMed, she was the Director of a Hospital-based HTA Center in Turkey (ANHTA) that covered HTA, innovation for medical devices and real-world evidence. In Turkey, she also served as a member of the Pharmaceuticals Reimbursement Committee of the Turkish Social Security Institution during transition to universal health coverage and was one of the co-authors of the reimbursement guidelines; the National Clinical Quality Coordinator of the Turkish MoH with the coordinating task of all activities around HTA, clinical guidelines and clinical quality; and the President of Turkish Evidence-Based Medicine Society. She is a professor of family medicine by background, with additional trainings in Italy, Spain, Canada, and the USA. She is recognized as an editor of eight books and the author of over 150 articles.